Login / Signup
Liqi Bi
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Ankylosing Spondylitis
Phase Ii
Top Venues
Clinical rheumatology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jia Li
,
Zhixin Xue
,
Zhen-Biao Wu
,
Liqi Bi
,
Huaxiang Liu
,
Lijun Wu
,
Shengyun Liu
,
Xiangyang Huang
,
Yong Wang
,
Yan Zhang
,
Wufang Qi
,
Lan He
,
Lie Dai
,
Lingyun Sun
,
Xiao-Mei Li
,
Zongwen Shuai
,
Yi Zhao
,
Yanyan Wang
,
Jian Xu
,
Hao Zhang
,
Hao Yu
,
Xiaoxiang Chen
,
Chunde Bao
Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trial.
Clinical rheumatology
41 (10) (2022)